Elevatebio names Ger Brophy interim CEO
Plus: Mineralys adds head of commercial ahead of NDA and updates from BlossomHill, Camurus, Sonoma, Kalvista, Hansa, Capricor
Weeks after Elevatebio LLC said Chairman and CEO David Hallal will become executive chairman, the genetic medicines organization said Ger Brophy is now serving as interim CEO and will join Hallal on its board. Brophy was most recently EVP of biopharma production at Avantor Inc., and has held roles including CTO and head of cell therapy at GE Healthcare Life Sciences. Elevatebio also named Bhakti Bhargava CFO late last month, replacing Vikas Sinha.
As Mineralys Therapeutics Inc. (NASDAQ:MLYS) awaits a pre-NDA meeting with FDA for hypertension therapy lorundrostat by year-end, the biotech has hired Eric Warren as its chief commercial officer. Warren stepped down last month as chief commercial officer of Esperion Therapeutics Inc. (NASDAQ:ESPR)...